Sinopharm
1099.HK
#2702
Rank
โ‚น615.16 B
Marketcap
โ‚น197.13
Share price
-2.73%
Change (1 day)
-2.28%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

EPS for Sinopharm (1099.HK)

EPS in 2024 (TTM): โ‚น5.31

According to Sinopharm's latest financial reports the company's current EPS (TTM) is โ‚น30.87. In 2025 the company made an earnings per share (EPS) of โ‚น30.87 an increase over its 2024 EPS that were of โ‚น29.20.

EPS history for Sinopharm from 2006 to 2024

Annual EPS

Year EPS Change
2025โ‚น30.875.7%
2024โ‚น29.20-24.52%
2023โ‚น38.693.65%
2022โ‚น37.331.3%
2021โ‚น36.8510.33%
2020โ‚น33.4017.26%
2019โ‚น28.495.44%
2018โ‚น27.02-0.87%
2017โ‚น27.2519.44%
2016โ‚น22.8215.3%
2015โ‚น19.7917.06%
2014โ‚น16.9121.9%
2013โ‚น13.8711.82%
2012โ‚น12.4025.24%
2011โ‚น9.9031.02%
2010โ‚น7.563.3%
2009โ‚น7.3246.85%
2008โ‚น4.9867.57%
2007โ‚น2.97310.24%
2006โ‚น0.72